Sirolimus-Eluting Stents for Very Long Lesions in ST-Elevated Myocardial Infarction
10.3969/j.issn.1000-3614.2009.03.003
- VernacularTitle:ST段抬高心肌梗死靶血管超长病变应用西罗莫司洗脱支架的临床与随访结果
- Author:
Shujuan CHENG
;
Hongbing YAN
;
Jian WANG
;
Shiying LI
;
Qingxiang LI
;
Hanjun ZHAO
;
Bin ZHENG
;
Li SONG
;
Yunpeng CHI
;
Zheng WU
;
Xiaojiang ZHANG
- Publication Type:Journal Article
- Keywords:
Myocardial infarction;
Sirolimus;
Stent;
Long lesion
- From:
Chinese Circulation Journal
2009;24(3):166-169
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To evaluate the safety and efficacy of overlapping Sirolimus-eluting stents (SES) in very long lesions during primary percutaneous coronary intervention (PCI) in patients with ST-elevated myocardial infarction (STEMI).Methods: A total of 297 consecutive patients with STEMI underwent primary PCI from January to December 2007 in our hospital were studied.We identified the patients who had 2 or more SES implanted in single long lesion with a single procedure.6 months angiographic and clinical follow-up was performed.The incidences of restenosis and major adverse cardiac event (MACE) during hospitalization and at the follow-up time were analyzed.Results: We identified 31 patients with 31 long lesions who had been implanted more than 2 stents.A median of 2.1 stents were implanted, the median lesion length was 47.2±10.3mm and a median implanted stents'length was 53.2±10.5 mm.6 months clinical follow up rate was 100% and 6 months angiographic follow-up rate was 74.2%, respectively.The incidence of MACE was 8.7% which including target lesion revascularization (TLR).No cardiac death and no fatal myocardial infarction were found.Conclusion: Implantation of SES for very long target lesions seemed to be safe and effective in patients with ST elevated myocardial infarction.Its long-term safety and effectiveness should be further investigated.
